28
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38961 | DP-1 | ||
DP-1, a Ganetespib degradation product, represents a fragment derived from SDC-TRAP-0063. Ganetespib itself functions as an inhibitor of heat shock protein 90 (HSP90), exhibiting notable anti-tumor properties. | |||
T38961L |
DP-1 hydrochloride
DP-1 hydrochloride(1472616-61-7 Free base) |
Drug Metabolite | Metabolism |
DP-1 hydrochloride是 SDC-TRAP-0063 的降解产物,是 Ganetespib 的一个片段。Ganetespib 是一种具有抗肿瘤活性的热休克蛋白 90 (HSP90) 抑制剂。 | |||
T4297 |
Flibanserin
BIMT-17BS,氟立班丝氨,Girosa,BIMT-17 |
Dopamine Receptor; 5-HT Receptor | GPCR/G Protein; Neuroscience |
Flibanserin (Girosa) 一种具有口服活性的 5-HT1A 受体激动剂和 5-HT2A 受体拮抗剂,Ki 值分别为 1 和 49 nM。它与多巴胺 D4 受体结合,Ki 值在 4 到 24 nM 之间。它是一种血清素能抗抑郁药,用于治疗性欲减退症。 | |||
T76219 |
MDP1
|
||
MDP1是一种源自蜂毒肽(melittin)的衍生肽,具有破坏革兰氏阳性及阴性细菌膜完整性的能力,能够通过膜损伤方式杀灭细菌。该化合物对金黄色葡萄球菌、大肠杆菌以及铜绿假单胞菌的耐多药(MDR)和参考菌株显示出高度的抗菌活性。 | |||
T62965 |
TDP1 Inhibitor-2
|
||
TDP1 Inhibitor-2 是一种 TDP1 (酪氨酰 -DNA 磷酸二酯酶 1) 的有效抑制剂 (IC50: 99 nM)。TDP1 Inhibitor-2 对 SCAN1 (脊髓小脑共济失调综合征伴轴突神经病变) 具有抑制作用 (IC50: 3.5 μM)。 | |||
T13109 |
TDP1 Inhibitor-1
|
Others | Others |
TDP1 Inhibitor-1 is a potent inhibitor of Tyrosyl-DNA Phosphodiesterase 1 (TDP1) (IC50 of 7 μM). | |||
T78033 |
SDP116
|
||
SDP116为合成的GPR116 Stachel肽衍生物,具备ADGRF5激动剂功能。 | |||
T76219L |
MDP1 acetate
|
||
MDP1 acetate为一种基于蜂毒肽(melittin)的衍生肽,能够破坏革兰氏阳性及革兰氏阴性细菌的膜完整性,进而通过膜损伤机制杀灭细菌。该化合物对金黄色葡萄球菌、大肠杆菌及铜绿假单胞菌等耐多药(MDR)与标准菌株表现出显著的抗菌活性。 | |||
T5386 |
Asapiprant
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Asapiprant 是一种强选择性DP1受体拮抗剂,Ki 值为 0.44 nM,对DP1受体表现出高亲和力和选择性。 | |||
T63349 |
Treprostinil diethanolamine
UT-15C |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Treprostinil diethanolamine (UT-15C) 是EP2、DP1和IP 的有效激动剂,对EP2、DP1、IP、EP1、EP4、EP3 和 FPKi 的值分别为 3.6、4.4、32.1、212、826、2505 和 4680 nM。Treprostinil diethanolamine 能够促使 cAMP 的上调,进而维持血管系统内的稳态,并造成人肺动脉的血管扩张。 | |||
T4635 |
Ralinepag
APD811 |
Others; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Others |
Ralinepag (APD811) 是一种可口服的非前列腺素前列环素 (IP) 受体激动剂,对人和大鼠 IP 受体以及人 DP1 受体的 EC50 分别为 8.5、530 和 850 nM。 | |||
T5150 |
Treprostinil
LRX-15,曲前列环素,Orenitram,曲前列尼尔,Remodulin |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Treprostinil (Orenitram) 是有效的 DP1、IP 和 EP2 激动剂,EC50分别为0.6、1.9 和 6.2 nM。 | |||
T5171 |
Treprostinil Sodium
曲前列尼尔钠,UT-15 |
VEGFR; c-RET; Prostaglandin Receptor | Angiogenesis; Apoptosis; GPCR/G Protein; Immunology/Inflammation; Tyrosine Kinase/Adaptors |
Treprostinil Sodium (UT-15) 是有效的 DP1、IP 和 EP2 激动剂,EC50分别为0.6、1.9 和 6.2 nM。 | |||
T15712 |
Laropiprant
MK-0524 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
Laropiprant (MK-0524) 是 DP receptor 的选择性拮抗剂,Ki 为 0.57 nM,对 TP 受体的 Ki 为 2.95 nM。 | |||
T14842 |
BW 245C
BW245C |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
BW 245C 是一种选择性的前列腺素类DP受体(DP1)激动剂,是一种前列腺素类似物,对胶原蛋白的聚集反应有抑制作用,可用于研究中风等疾病。 | |||
T7359 |
CAY10471 Racemate
TM30089 Racemate,3-[[(4-氟苯基)磺酰基]甲基氨基]-1,2,3,4-四氢-9H-咔唑-9-乙酸 |
GPR; Prostaglandin Receptor | Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation |
CAY10471 Racemate (TM30089 Racemate) 是一种高选择性的 CRTH2/DP 2 受体拮抗剂,对 hCRTH2 的Ki 值为 0.6 nM,对其选择性远高于人血栓素 A2 受体 TP 或 PGD2 受体 DP。它对大小鼠的同源 CRTH2 也具有拮抗作用。 | |||
T3306 |
PF-04418948
PF 04418948,PF04418948 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
PF-04418948 是一种可口服的,选择性的前列腺素EP2受体拮抗剂,IC50为16 nM。 | |||
T5482 |
TG4-155
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
TG4-155 是一种脑渗透性 EP2 拮抗剂,对 EP2 和 DP1 具有低纳摩尔的拮抗活性。它作用于 EP2 的 KB 为 2.4 nM,比对 DP1 受体的选择性高 14 倍,比对 EP1、EP3、EP4 和 IP 的选择性比高 550-4750 倍。 | |||
T6399 |
AZD1981
|
GPR; Prostaglandin Receptor | Endocrinology/Hormones; GPCR/G Protein; Immunology/Inflammation |
AZD1981 是一种有效且特异性的 CRTh2 (DP2) 受体拮抗剂,IC50为 4 nM,用于研究哮喘、绝经后、药代动力学、哮喘患者和药物相互作用等治疗和基础科学的试验。 | |||
T15829 | L 888607 Racemate | Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic |
L 888607 Racemate is a selective antagonist of prostaglandin D2 receptor subtype 1 (DP1) (Kis: 132 nM and 17 nM for DP1 and thromboxane A2 receptor (TP), respectively). | |||
T39165 |
Treprostinil palmitil
Treprostinil palmitil,INS-1009 |
||
Treprostinil Palmitil (TP), a prodrug of the DP1 and EP2 agonist Treprostinil (UT-15), exhibits EC50 values of 0.6 and 6.2 nM, respectively. It is a pure prodrug without any inherent binding affinity for G-protein coupled receptors, including prostanoid receptors. | |||
T69967 |
Laropiprant analog
|
||
Laropiprant analog is an antagonist of the prostaglandin PGD2 receptor DP1. | |||
T28651 |
S-5751
S 5751 |
||
S-5751, a prostanoid DP (DP1) antagonist, is used potentially for the treatment of bronchial asthma. | |||
T36545 |
Prostaglandin D2 methyl ester
Prostaglandin D2 methyl ester |
||
Prostaglandin D2 (PGD2) is the major eicosanoid product of mast cells and is produced in large quantities by hematopoietic PGD synthase during allergic and asthmatic anaphylaxis. It causes vasodilation, flushing, hypotension, and is an inhibitor of platelet aggregation. Prostaglandin D2 methyl ester (PGD2 methyl ester) is a more lipid-soluble, cell-permeable prodrug form of PGD2. It binds to the human and mouse PGD2 receptors (DP1 and CRTH2/DP2) with 5-10 fold lower affinity than PGD2. | |||
T4981 |
Anisotropine Methylbromide
|
Prostaglandin Receptor; AChR | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Anisotropine Methylbromide 是一种抗胆碱能药物,已用于缓解胃肠道痉挛和抑制胃酸分泌。 | |||
T38365 |
CAY10597
|
||
The biological effects of prostaglandin D2 (PGD2) are transduced by at least two 7-transmembrane G protein-coupled receptors, designated DP1 and CRTH2/DP2. In humans, CRTH2/DP2 is expressed on Th2 cells, eosinophils, and basophils where it mediates the chemotactic activity of PGD2. CAY10597, as a racemic mixture, is a potent CRTH2/DP2 receptor antagonist that binds to the human receptor with a Ki value of 37 nM. The R enantiomer is slightly more potent exhibiting Ki values of 23 and 22 nM at the... | |||
T10891 |
CRTH2-IN-1
Ramatroban analog |
P450 | Metabolism |
CRTH2-IN-1 is a selective prostaglandin D2 receptor DP2 (CRTH2) antagonist, a Ramatroban analog, with an IC50 of 6 nM in the human DP2 binding assay. | |||
T15828 |
L 888607
|
Others | Others |
L 888607 is an effective and selective CRTH2 agonist (Ki: 0.8 nM). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T19329 |
Fructo-oligosaccharide DP12/GF11
蔗果十二糖 |
Others | Others |
Fructo-oligosaccharide DP12/GF11 is a member of fructooligosaccharides (FOS) characterized by a degree of polymerization (DP) of 12. FOS compounds consist of 11 fructose units connected by (2→1)-β-glycosidic bonds, with a lone D-glucosyl unit located at the non-reducing end. | |||
T82369 |
Fructo-oligosaccharide DP14
|
||
Fructo-oligosaccharide DP14为从Atractylodes lancea中提取的寡糖。 | |||
T19328 |
Fructo-oligosaccharide DP11/GF10
|
Others | Others |
Fructo-oligosaccharide DP11/GF10 is a fructooligosaccharide (FOS) compound with a degree of polymerization (DP) equal to 11. FOS consists of 10 fructose units connected by (2→1)-β-glycosidic bonds, with a single D-glucosyl unit present at the non-reducing end. | |||
T82370 |
Fructo-oligosaccharide DP13
|
||
Fructo-oligosaccharide DP13,一种Inulin型低聚果糖,可从Morinda Officinalis中分离。 | |||
TN2358 |
Fructo-oligosaccharide DP10/GF9
蔗果十糖,Fructo-oligosaccharide DP10/GF9 |
Others | Others |
Fructo-oligosaccharide DP10/GF9 is a compound classified as a fructooligosaccharide (FOS) with a degree of polymerization (DP) of 10. FOS consists of a chain of 9 fructose units connected by (2→1)-β-glycosidic bonds, with a lone D-glucosyl unit located at the non-reducing end. |